Clinical trial
MIRSEP - MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK
NCT07597122 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MIRSEP - MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 56 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis and septic shock